#drug pricing

Total payments for the HIV prevention pill exceeded $2 billion in 2018.

A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.

Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.

Oncologist wins Senate backing by a vote of 72 to 18.

“Overall, the candidates seemed well informed around HIV/AIDS issues.”

A look at what the law says about buying prescription drugs from Canada.

In the form of direct quotes from the participants

Gilead Sciences CEO defends high drug prices and claims the CDC does not own the patent to HIV prevention pill Truvada.

Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.

Insurance companies can no longer implement harmful co-pay accumulator policies.

Activists want future and retroactive royalties to pay for a national PrEP program.

In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.

Stop me if you’ve heard this one before.

If the price is lowered with a generic version of PrEP, activists say, “we could end the HIV epidemic without a vaccine.”

A look at the 2019 State of the Union address

Older drugs, many on the market for years, are rising in cost much faster than inflation.